| Product Code: ETC13334629 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Neoantigen Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Neoantigen Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Neoantigen Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Neoantigen Market - Industry Life Cycle |
3.4 Europe Neoantigen Market - Porter's Five Forces |
3.5 Europe Neoantigen Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Neoantigen Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Europe Neoantigen Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Europe Neoantigen Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Europe Neoantigen Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Europe Neoantigen Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Neoantigen Market Trends |
6 Europe Neoantigen Market, 2021 - 2031 |
6.1 Europe Neoantigen Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Neoantigen Market, Revenues & Volume, By Personalized Neoantigens, 2021 - 2031 |
6.1.3 Europe Neoantigen Market, Revenues & Volume, By Shared Neoantigens, 2021 - 2031 |
6.2 Europe Neoantigen Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Neoantigen Market, Revenues & Volume, By DNA Sequencing, 2021 - 2031 |
6.2.3 Europe Neoantigen Market, Revenues & Volume, By RNA Sequencing, 2021 - 2031 |
6.2.4 Europe Neoantigen Market, Revenues & Volume, By Mass Spectrometry, 2021 - 2031 |
6.3 Europe Neoantigen Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Neoantigen Market, Revenues & Volume, By Cancer Immunotherapy, 2021 - 2031 |
6.3.3 Europe Neoantigen Market, Revenues & Volume, By Vaccine Development, 2021 - 2031 |
6.3.4 Europe Neoantigen Market, Revenues & Volume, By Drug Discovery, 2021 - 2031 |
6.4 Europe Neoantigen Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe Neoantigen Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Europe Neoantigen Market, Revenues & Volume, By Research Institutes, 2021 - 2031 |
6.4.4 Europe Neoantigen Market, Revenues & Volume, By Biotechnology Companies, 2020 - 2028 |
7 Europe Neoantigen Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Neoantigen Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 United Kingdom (UK) Neoantigen Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Germany Neoantigen Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 France Neoantigen Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.4 Poland Neoantigen Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.5 Spain Neoantigen Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.6 Rest of Europe Neoantigen Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 Europe Neoantigen Market Revenues & Volume Share, By Technology, 2021 & 2031F |
7.3.1 United Kingdom (UK) Neoantigen Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.2 Germany Neoantigen Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.3 France Neoantigen Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.4 Poland Neoantigen Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.5 Spain Neoantigen Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.6 Rest of Europe Neoantigen Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4 Europe Neoantigen Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.1 United Kingdom (UK) Neoantigen Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.2 Germany Neoantigen Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.3 France Neoantigen Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.4 Poland Neoantigen Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.5 Spain Neoantigen Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.6 Rest of Europe Neoantigen Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 Europe Neoantigen Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.1 United Kingdom (UK) Neoantigen Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.2 Germany Neoantigen Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.3 France Neoantigen Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.4 Poland Neoantigen Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.5 Spain Neoantigen Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.6 Rest of Europe Neoantigen Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Europe Neoantigen Market Key Performance Indicators |
9 Europe Neoantigen Market - Export/Import By Countries Assessment |
10 Europe Neoantigen Market - Opportunity Assessment |
10.1 Europe Neoantigen Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Neoantigen Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 Europe Neoantigen Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.4 Europe Neoantigen Market Opportunity Assessment, By Application, 2021 & 2031F |
10.5 Europe Neoantigen Market Opportunity Assessment, By End User, 2021 & 2031F |
11 Europe Neoantigen Market - Competitive Landscape |
11.1 Europe Neoantigen Market Revenue Share, By Companies, 2022 |
11.2 Europe Neoantigen Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here